Работы, на которые ссылается эта работа

Работ: 131

Работа: The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray, Mathieu Laversanne, Hyuna Sung +4
Статья2024Цитирований: 19
ABI
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25
Статья2021Цитирований: 5
ABI
The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials
Vahid Moradi, Azadeh Omidkhoda, Naser Ahmadbeigi
Обзорная статья2023Цитирований: 4
ABI
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi +2
Обзорная статья2024Цитирований: 4
ABI
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Philip W. Kantoff, Celestia S. Higano, Neal D. Shore +10
Статья2010Цитирований: 3
ABI
Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
Bihui Cao, Manting Liu, Jingjun Huang +17
Статья2021Цитирований: 3
ABI
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Changsong Qi, Jifang Gong, Jian Li +23
Статья2022Цитирований: 3
ABI
Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance
Yanping Yang, Raymond H. Y. Louie, Janusz Puc +6
Статья2023Цитирований: 3
ABI
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova +13
Статья2010Цитирований: 3
ABI
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner +32
Статья2018Цитирований: 3
ABI
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
Eleonora Pinto, Lisa A. Lione, Mirco Compagnone +8
Обзорная статья2025Цитирований: 3
ABI
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh +2
Обзорная статья2025Цитирований: 3
ABI
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière +27
Статья2021Цитирований: 2
ABI
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody +8
Обзорная статья2023Цитирований: 2
ABI
Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors
Xiuxiu Zhu, Jun Chen, Wuling Li +8
Статья2023Цитирований: 2
ABI
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
Changsong Qi, Chang Liu, Zhi Peng +31
Статья2025Цитирований: 2
ABI
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Mohammad Kazemi, Maryam Sadri, Alireza Najafi +4
Обзорная статья2022Цитирований: 2
ABI
Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12
Xiaowei Chi, Peiwei Yang, Erhao Zhang +9
Статья2019Цитирований: 2
ABI
EpCAM Signaling in Oral Cancer Stem Cells: Implications for Metastasis, Tumorigenicity, and Therapeutic Strategies
Chuan‐Hsin Chang, Chung‐Che Tsai, Fu‐Ming Tsai +3
Обзорная статья2025Цитирований: 2
ABI
Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson, Nicholas G. Minutolo, Saar Gill +1
Обзорная статья2020Цитирований: 2
ABI
Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo
Yanjing Song, Chuan Tong, Yao Wang +8
Статья2017Цитирований: 2
ABI
Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
Kelong Tao, Meng He, Feng Tao +4
Статья2018Цитирований: 2
ABI
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer
Hua Jiang, Zhimin Shi, Peng Wang +9
Статья2018Цитирований: 2
ABI
Combination therapy of DKK1 inhibition and <scp>NKG2D</scp> chimeric antigen receptor <scp>T</scp> cells for the treatment of gastric cancer
Yipeng Zhang, Kaijie Liang, Xiaoyu Zhou +8
Статья2023Цитирований: 2
ABI
Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen +2
Обзорная статья2024Цитирований: 2
ABI